Protein crystallization in short-peptide supramolecular hydrogels: A versatile strategy towards biotechnological composite materials by Conejero-Muriel, Mayte et al.
CrystEngComm
PAPER
Cite this: CrystEngComm, 2015, 17,
8072
Received 30th April 2015,
Accepted 8th June 2015
DOI: 10.1039/c5ce00850f
www.rsc.org/crystengcomm
Protein crystallization in short-peptide
supramolecular hydrogels: a versatile strategy
towards biotechnological composite materials†
Mayte Conejero-Muriel,a Rafael Contreras-Montoya,b Juan J. Díaz-Mochón,*c
Luis Álvarez de Cienfuegos*b and José A. Gavira*a
Protein crystallization in hydrogels has been explored with the main purpose of facilitating the growth of
high quality crystals while increasing their size to enhance their manipulation. New avenues are currently
being built for the use of protein crystals as source materials to create sensors and drug delivery vehicles,
to name just a few. In this sense, short-peptide supramolecular hydrogels may play a crucial role in inte-
grating protein crystals within a wider range of applications. In this article, we show that protein crystalliza-
tion in short-peptide supramolecular hydrogels is feasible and independent of the type of peptide that
forms the hydrogel and/or the protein, although the output is not always the same. As a general trend, it is
confirmed that hydrogel fibers are always incorporated within crystals so that novel composite materials
for biotechnological applications with enhanced properties are produced.
Introduction
The field of protein crystallization is of crucial importance to
unveil the secrets of biological systems at the molecular
level.1 It has an immediate impact in structural proteomic/
genomic projects as well as in rational drug design. For this
reason, growing crystals of adequate size and quality for X-ray
diffraction is often the major bottleneck. Many different fac-
tors have an influence on the whole process of protein crystal-
lization and therefore a multitude of methods, strategies and
techniques have been developed to attain success.1–3 In most
cases, the optimal strategy to obtain crystals of a particular
protein is found serendipitously.4 One emerging strategy in
this field employs the use of hydrogels as media or carriers
for the growth of protein crystals.5 It has been demonstrated
that the use of conventional macromolecular hydrogels such
as agarose, polyacrylamide, silica and sephadex has a direct
impact on the formation of protein crystals and their quality.6
Indeed, crystals of exceptional size and quality are obtained
within hydrogels when compared with other traditional crys-
tallization techniques. This can be explained by (i) the physi-
cal properties of the hydrogel which eliminates sedimenta-
tion, convection current7 and acts as impurity filter media,8
and (ii) their molecular influence, as hydrogel fibers can
interact directly with protein molecules,9,10 having a final
composite formed by polymeric fibers of agarose,11 silica,12,13
and PEG-based hydrogels,14 incorporated within the crystal
lattices of protein crystals. This incorporation occurs during
the growth process, thus influencing crystal polymorphism,15
enantiomorphism,16 habits17 and stabilities.18
Considering this, very recently we have shown that novel
short-peptide supramolecular hydrogels serve as convective
free media to grow protein crystals of high quality.19 This
family of supramolecular hydrogels, which have already been
used successfully in a wide range of biomedical applications
due to their biocompatibility,20–24 has been now revealed as
excellent media for protein crystallization, thus expanding
the number of biotechnological applications that these mate-
rials can be developed for. Since polymeric hydrogel fibers
are incorporated within the crystal structures of proteins, we
reasoned that the peptidic nature of supramolecular hydrogel
fibers could act as a native environment for proteins. More
importantly, given that these peptide fibers are chiral, we
thought that they would be ideal media to study the influ-
ence of chirality in the process of protein crystallization.
Although there are scarce examples in the literature about
this influence, recently, the group of Asherie has proved that
the chirality of small additives has an effect on the crystal
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quality of lysozyme25 and the habit of thaumatin.26 Similarly,
we have also found a chiral influence on the crystal growth
and quality of model proteins using homochiral peptidic
hydrogels. To reinforce these preliminary results and to study
in more detail the influence of chirality in protein crystalliza-
tion, the use of a bigger number of homochiral hydrogels
was required. There is a wide range of low molecular weight
gelators (LMWG) that could be tested for protein crystalliza-
tion showing different strengths and fiber properties as a
function of their composition and preparation conditions.27
In the present article, we have extended the process of pro-
tein crystallization using short-peptide supramolecular hydro-
gels of the well-known Fmoc-dipeptides family28–31 and tested
them with different proteins. These types of hydrogels have
already been used to produce silver crystalline nanoclusters
as an elegant application of peptide-based hydrogels for
green chemistry applications.32 Peptide-based hydrogels have
the advantages of generating hydrogels at room temperature
under mild conditions, thus allowing direct mixing of the
protein with the hydrogel.
Our results show that short-peptide-based hydrogels are
alternative media to obtain high quality protein crystals.
Moreover, some particular protein–hydrogel combinations
produced crystals that diffract X-ray at atomic resolution,
therefore justifying the use of novel peptide-based hydrogels.
As the incorporation of the hydrogel is proven in all tested
proteins, this is a versatile strategy to produce novel compos-
ite materials with potential biotechnological applications.
Results and discussion
We have recently shown that cysteine-based peptide ĲN,N′-
diĲbenzoyl)-L/D-cysteine diamide) hydrogels 1 and 2 are not
only compatible with protein crystallogenesis producing crys-
tals that diffract X-ray to a very high resolution, but also
effectively behave as homochiral defined media that allow
the study of chirality in crystallogenesis.19 These novel results
bring new expectations to the field of protein crystallization
and can generate an enormous interest for this kind of mate-
rial. To increase the applicability of these media and to make
them user-friendly to structural laboratories, these peptides
have to be commercially available and their respective hydro-
gels have to be easily prepared. With this idea in mind, in
this work we tested two commercially available short pep-
tides, Fmoc-FF-OH and Fmoc-AA-OH, capable of forming
supramolecular hydrogels (3 and 4, respectively) under mild
conditions following a simple protocol, as well as the already
tested hydrogels 1 and 2 (Fig. 1). We then selected four
model proteins, namely lysozyme, thaumatin, glucose isomer-
ase and insulin, to cover a wider range of molecular masses
and isoelectric points (Table 1), and a formamidase from B.
cereus that produced a crystal with the highest resolution ever
reported using the dicysteine-based peptide hydrogel 2 as
media. With these selected media (hydrogels 1 to 4), we stud-
ied the influence that both chemical compositions (3 vs. 4
and vs. cysteine-dipeptides) and chirality (L vs. D-dicysteine)
has in protein crystallogenesis.
The selected Fmoc-dipeptide hydrogels 3 and 4 can be eas-
ily prepared by solvent switch as it has been previously
described by the group of Gazit,33 and as explained in the
Experimental section (see below). The possibility of generat-
ing the hydrogels at room temperature with a mixture of
water and 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) allowed,
for the first time, the in situ formation of hydrogel using a
protein solution. We selected hydrogel 3 to set-up two types
of experimental protocols: (i) diffusion of protein solution
placed on top of the hydrogel (3) and (ii) in situ mixing of the
protein solution and hydrogel precursor (3b).
Our results showed that the four selected peptide-based
hydrogels (1–4) were compatible with protein crystallization
(Table 1). In Fig. 2, examples of well-faceted crystals of all
selected proteins in hydrogels 1–4 are shown. For each pro-
tein, crystals grown in different hydrogels always presented
the same shape, varying only in number and size. Preliminary
crystallization experiments with insulin also produced crys-
tals in hydrogels 1, 2 and 4.
Following our previous work, lysozyme was first assayed to
study the influence of hydrogel chirality (1 vs. 2) and chemi-
cal composition (3 vs. 4 and vs. cysteine-dipeptides). Taking
into account the fact that counter-diffusion experiments pro-
duce a supersaturation gradient, crystal number and size vary
along the hydrogel tube with the biggest crystals appearing at
the bottom of the Eppendorf tube. Therefore, we compared
the crystals of the biggest size from each hydrogel. In all
experiments, a typical development of the counter-diffusion
technique was observed. Crystal obtained in hydrogels 1 and
2 were of similar size of around 350 to 400 μm in their longer
axis (Table S1†). However, crystals grown in hydrogel 4 were
bigger (489 μm) than those grown in 3 (167 μm), as expected
from the higher nucleation density. Nucleation induction in
3 was even higher than in agarose, a well-known nucleation
promoter of tetragonal lysozyme.10 This behavior was
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observed using both experimental set-ups 3 and 3b. In terms
of X-ray diffraction, there were no remarkable differences
among all the hydrogels (Fig. 3A). However, it is worth men-
tioning that crystals obtained in hydrogel 4 showed a slightly
lower quality, i.e. lower resolution limit, higher mosaicity and
B factor, while crystals obtained in hydrogel 3 diffracted X-ray
beyond 1.1 Å, even higher than our previous results with
hydrogels 1 and 2, and agarose (Table S3†). From these
results we could not infer any chirality effect, while a clear
influence of the chemical composition was observed on the
evolution of nucleation (i.e. crystal size).
Glucose isomerase was previously studied in hydrogels 1
and 2 showing a strong chirality influence on polymorphism.
Here, a clear effect on the evolution of the crystallization was
also found. In 1, a higher nucleation density, giving rise to
crystals (48 μm) smaller than 2 (196 μm), was observed (Table
S1†). Chemical compositions also had a role in the control of
the nucleation as deduced from the difference in average
maximum crystal size, being 346 μm and 209 μm in 3 and 4,
respectively. In this case, crystals obtained in hydrogel 3 had
a similar quality to crystals grown in 1 and 2, as published
previously.19 The best quality crystals were obtained in those
grown in hydrogels 4 and 3b. It is also remarkable that in
both cases, with lysozyme and glucose isomerase, crystals
obtained with the in situ mixed set-up were of the highest
quality among all the tested hydrogels even in the presence
of HFIP (Fig. 3B and Table S4†).
Thaumatin was also studied. Its crystallization behaviour
was also affected by the hydrogel nature. Crystals obtained in
hydrogels 2 and 3 and agarose were of similar size with a
maximum length of approximately 400 μm, while in the case
of crystals grown in 1 and 4 the maximum length was 143
μm which corresponded to a higher nucleation density.
Therefore, both the chirality and chemical composition
influenced the nucleation behaviour of thaumatin. In this
case, the in situ mixed set-up did not produce any crystal but
a full aggregation of the mix. This may be due to either the
presence of the solvent HFIP or the interaction between the
protein and the hydrogel precursor.
Thaumatin crystal qualities were remarkably good in all
hydrogels. Small differences were observed at the resolution
limit level. For instance, crystals from 1 and 2 are compara-
ble to the best crystals grown in agarose,6 diffracting X-ray at
the attainable limit with the used configuration 1.05 Å
(Fig. 3C and Table S5†).
Once more, there were clear effects arising from chirality
and chemical composition. It is worth noting that crystals of
similar size obtained in hydrogels 1 and 4 (two chemical





(°C) Agarose 1 2 3 3b 4MW pI Chargeb
Lysozyme 14 313 9.04 13.0 200 91a 6% w/v NaCl, 50 mM sodium acetate (pH 4.5) 20 C C C X X X
Glucose
isomerase
43 227 5.17 16.6 120 90/50/40a 10% PEG 1 K, 0.2 M MgCl2, 0.1 M Hepes (pH 7.0) 20 C C C X X X
Thaumatin 22 205 7.93 2.0 100 160/50a 45% Ĳw/v) potassium sodium tartrate (pH 7.56) 20 C X X X X X
Formamidase 38 632 5.93 16.4 28 14.5a 25% PEG 4 K, 0.2 M NH4 sulphate, 0.1 M sodium
acetate (pH 4.6)
20 C X C O O O
Insulin 17 260 5.59 −5.1 6 0.9/1.8/2.7a 30% acetone, 2 mM ZnCl2, 28 mM sodium citrate
(pH 7.0)
4 X X X O O C
C: crystals were obtained, X: crystals were characterized by X-ray diffraction, O: no crystals. a Final protein concentration after mixing with the
hydrogel precursor. b Net charge at the crystallization pH.
Fig. 2 Crystals of lysozyme (A), glucose isomerase (B), thaumatin (C and D),
insulin (E) and FASE (F) grown in hydrogels 4, 3, 2, 4, 2 and 1, respectively.
Fig. 3 Average values of the X-ray standard quality indicators for lysozyme
(A), glucose isomerase (B), thaumatin (C) and insulin (D) crystals grown in
different peptide-based hydrogels and in agarose from data sets collected
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environments) were of different qualities, while those grown
in 1 and 2 have the same chemical environment but different
chiralities; their crystal sizes were different but their qualities
were comparable.
Preliminary experiments with insulin were also carried out
using hydrogels 1 and 2 and agarose. Crystals were obtained
in all the cases in low number and of small size (Fig. 2E).
The low nucleation density after several months indicates
that the range of concentration selected (supersaturation)
was too low. Still, all crystals grown in hydrogels 1 and 2 were
of similar quality to crystals grown in agarose, diffracting
X-ray to a high resolution of 1.5 Å (Fig. 3D and Table S6†).
A new set of experiments has been conducted including
hydrogel 3 (using both experimental set-ups) and 4. Until
now, crystals of similar size have been obtained in 4 but no
nucleation has been observed with 3 for the same period of
time, which can be attributed to an inhibition effect when
compared with 1, 2, 4 and agarose.
We also studied the target protein FASE which produced
the best crystals ever obtained in hydrogel 219 in order to test
the potential of hydrogels 3 and 4, including hydrogel 1
which did not produce good diffracting crystals in our previ-
ous study. Surprisingly, in this case, crystals were only
obtained in hydrogel 1. More interestingly, the crystals were
flat hexagonal plates (Fig. 2F), which diffracted X-ray to a res-
olution of 2.7 Å (Table S7†); the polymorph obtained, P622,
was different than the previous one, C121, obtained in hydro-
gel 2.19 This new polymorph obtained only in 1 reinforces the
role of chirality in polymorphism and agrees with our previ-
ous finding with glucose isomerase. This result needs to be
confirmed upon structural determination from improved
crystals of FASE.
We also studied the influence of the different hydrogels
on the dissolution of lysozyme, glucose isomerase and
thaumatin. We initially characterized the dissolution behav-
iour of the model protein crystals obtained in solution by
transferring the crystals into pure MilliQ water (see the Exper-
imental section for details). Lysozyme crystals of 290 μm
dissolved almost completely in approximately 100 seconds
(Fig. S1A†). Unexpectedly, glucose isomerase crystals lasted
for more than 4 hours (Fig. S1B†) and in the case of
thaumatin crystals, the complete dissolution required 24
hours (Fig. S1C†). As pointed out by Jones and Ulrich, protein
crystals may be considered as solvates of salts,34 which may
explain the complex dissolution behaviour observed with the
lysozyme polymorph.35,36
Lysozyme crystals grown in agarose and hydrogels 1, 2
and 3 dissolved, in average, slower than hydrogel-free grown
crystals (Fig. 4). This can be simply explained by the fact that
protein crystals incorporate hydrogel fibers during their
growth11,14,37 and therefore, proteins have to diffuse through
the protein-free hydrogel. Surprisingly, the crystal obtained in
hydrogel 4 lasted for 2 hours and a half, and this long time
could not be explained by the crystal size, since both were of
similar size (Fig. 4 and Table S1†). We repeated the dissolu-
tion experiment four more times for crystals grown in
hydrogel 4 and three more times for crystals grown in
agarose, giving out an average dissolution time of 139.6 ±
52.4 min and 5.5 ± 0.91 min for 4 and agarose, respectively
(Fig. 5 and Table S8†).
We followed a similar protocol to study the dissolution
experiments of glucose isomerase (Fig. S2†). As already men-
tioned, the dissolution of hydrogel-free crystals lasted longer
than expected. Surprisingly, the presence of the hydrogels in
all the cases seems to accelerate the dissolution process. This
effect was evidently less pronounced in the case of 2 (Table
S8 and Fig. S4A†) and also in crystals grown in 1 if we corre-
late the size of the crystal with the dissolution time. The
Fig. 4 Time-lapse dissolution experiments of lysozyme crystals
obtained in agarose (A), hydrogel 1 (B), 2 (C), 3 (D) and 4 (E). The first
column shows the cleaned crystals in a 2 μL isotonic precipitant
solution. Note the bar size scale at the bottom left of the first pictures.
The second column and subsequent columns correspond to the
dissolution of each crystal when transferred to a 200 μL drop of MilliQ
water. The time evolution is shown in each image. For comparison
purposes, the last column is grouped in a yellow border, and the time
of the almost final dissolution step is noted in the same time unit.
Fig. 5 Average dissolution time of tetragonal lysozyme crystals grown
in a hydrogel-free solution and in hydrogels including agarose. Since
crystals from hydrogel 4 lasted much longer, we have plotted their dis-
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same correlation for 3 and 4 showed that the dissolution rate
(aprox. 3.2 μm min−1) was the same in both hydrogels, and
faster than that for 1 and 2 (approx. 0.7 μm min−1).
Thaumatin represented an extreme case in this study. The
dissolution of the hydrogel-free crystals took more than one
day for crystals of 390 μm. These results also conditioned the
dissolution experiments for all hydrogels (Fig. S3†). Table S8
and Fig. S4B† show that the dissolution time of crystals from
1 and 2 were similar among them but different than those
from hydrogels 3 and 4, which both quadrupled the dissolu-
tion time compared to the hydrogel-free crystals. From these
results, it is clear that chirality does not have an effect on pro-
tein crystal dissolution, while subtle changes in the chemical
composition have a major impact on the crystal dissolution.
Experimental
All materials were of analytical grade and used without fur-
ther purification. Compounds 1 and 2 were synthesized by
the solid phase protocol previously described by us.19 Fmoc-
FF and Fmoc-AA were bought from Bachem.
Gel preparation
Hydrogels 1 and 2 (0.1% w/v) were prepared in MilliQ water by
heating in a closed vial, as previously described.19 Hydrogels
3 and 4 (0.5% w/v) were prepared by dissolving the peptide in
5 μL of DMSO to a final concentration of 100 mg mL−1
followed by the addition of 100 μL of MilliQ water. The excess
DMSO in the formed hydrogels was then removed by the addi-
tion of an excess of MilliQ water in each Eppendorf tube for
12 hours. This process was repeated several times for a week.
Since DMSO is not compatible with protein crystallization,
HFIP was selected for the in situ protein–hydrogel formation.
For the in situ protein–hydrogel incorporation, hydrogels 3
and 4 were prepared by dissolving the peptide (50 mg mL−1)
in 10 μL of HFIP followed by the addition of 100 μL of protein
solution in MilliQ water to generate hydrogels at the same
final concentration (0.5% w/v). The proteins and concentra-
tions used for these experiments are summarized in Table 1.
Protein preparation and production
Several commercial proteins and FASE from B. cereus were
selected to cover a wider range of molecular masses and iso-
electric points (Table 1).
Lysozyme (chicken HEWL), thaumatin from Thaumatococcus
daniellii and recombinant human insulin were purchased as
lyophilized powders from Sigma (L6876, T7638 and I2643,
respectively). Glucose isomerase ĲD-xylose-ketol-isomerase)
from S. rubiginosus was purchased as a crystal suspension
from Hampton Research (HR7-100). Lysozyme was dissolved
and dialyzed in 50 mM sodium acetate (pH 4.5). Glucose
isomerase crystals were dissolved in water and extensively
dialyzed against 100 mM Hepes (pH 7.0). Thaumatin was
dissolved in water. Insulin was dissolved in 6 mM HCl, 5 mM
ZnCl2 and 28 mM sodium citrate (pH 7.0).
B. cereus formamidase (FASE) was expressed in E. coli
BL21 (DE3) and purified following an already described pro-
tocol. Concentrated protein in 20 mM Tris-HCl (pH 8.0) was
used for crystallization assays.
Crystallization experiments
Counter-diffusion technique with a two layer configuration (2 L)38
was used to set-up crystallization experiments in Eppendorf
tubes (Fig. S5†). Two different set-ups were tested. In the first
case the protein was allowed to diffuse within a preset hydro-
gel column (50 μL) for one week while in the second case
protein solutions were directly mixed with the hydrogel pre-
cursor to a final volume of 50 μL, as explained above, and
allowed to gel. Then, 50 μL of the precipitant solution was
added on top of the hydrogel plus the protein layer to start
the crystallization experiment. A schematic representation of
both procedures is illustrated in Fig. 6 and the crystallization
conditions are summarized in Table 1.
Experiments were performed at 20 °C except for the insu-
lin experiments that were performed at 4 °C.
Crystal dissolution
Crystals were extracted from the hydrogels and deposited in a
plastic Petri dish. The bigger range sized protein crystals
Fig. 6 Crystallization set-ups: step 1, (left) protein is allowed to diffuse
within a preset hydrogel for 1 week or (right) directly mixed with the
hydrogel precursor; step 2, protein is removed (left) and the
precipitant is allowed to diffuse within the hydrogel containing protein;
step 3, crystals are extracted from the Eppendorf tube and collected
with the help of a LithoLoop; step 4, crystals are cryo-protected with
15/20% v/v glycerol prior to flash-cooling in liquid nitrogen; step 5,
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were selected to carry out the dissolution experiments. Crys-
tals were first cleaned with their recovered precipitant solu-
tion and finally placed in a 2 μL drop of isotonic precipitant
solution. After that, the crystals were transferred to a 200 μL
drop of MilliQ water (t = 0 s) and the dissolution evolution
was monitored with an optical microscope at room tempera-
ture. The Petri dish was kept sealed with vacuum grease to
avoid evaporation. In experiments with a higher nucleation
density, a group of small crystals contained in the hydrogel
was transferred to the 200 μL drop of MilliQ. Pictures were
acquired with a ProgRes® CapturePro 2.8 detector (JENOPTIK
optical systems, GmbH). Selected crystals were measured and
used to determine the average crystal size. For comparison
purposes, we have used the longest dimensions of each
measurement.
X-ray data collection and analysis
Crystal quality was determined using X-ray diffraction data
collected at beam-lines Xaloc (ALBA) and ID23-1 (ESRF) of
the Spanish and European synchrotron radiation sources.
Briefly, crystals were extracted from the hydrogel using a
Pipetman (200 μL) with the tip-end cut and deposited in a
plastic Petri dish. Drops of the recovered precipitant or the
precipitant plus a cryoprotectant (20% v/v glycerol) were
deposited nearby. Selected crystals were transferred to either
the precipitant solution for final cleaning, or directly to the
cryoprotectant solution with the help of a LithoLoop (Molecu-
lar Dimensions Inc.). Crystals were then flash-cooled in liq-
uid nitrogen and saved for data collection. Data collection
configuration was kept constant (Table S2†) for each series
and protein except for glucose isomerase which was com-
pleted from data collected at the ESRF (Tables S3 to S7†).
Conclusions
Our results demonstrate that short-peptide supramolecular
hydrogels are excellent media to obtain high-quality protein
crystals. The incorporation of supramolecular hydrogels to
the standard chemical toolbox, used to obtain protein crys-
tals, needs to be considered. The influence of the hydrogels
on the crystallogenesis of proteins overcomes the structural
influence of the hydrogel, since all tested hydrogels can be
considered identical from the structural point of view,
highlighting the chemical relevance to the point of stereo-
chemical contribution. As demonstrated in this work,
enantiomeric hydrogels influence differently the nucleation
and growth of the same protein. Dramatic effects were also
observed when the chemical differences between hydrogels
are considered. We have further investigated the possibility
of mixing in situ the protein solution with the hydrogel pre-
cursor in the case of Fmoc-FF-OH (3) and showed that, except
for thaumatin, this preparation procedure is feasible, facili-
tating the use of peptide-based hydrogels as a tool to improve
crystal quality. The influence of the hydrogel on the final
crystal size could not be correlated with the final crystal qual-
ity as characterized from the X-ray diffraction experiments.
We have proven that it is possible to find the right pro-
tein–gel couple to produce materials of specific composition
with particular properties, dissolution rate, polymorphism,
etc., which may be exploited either technologically or
pharmaceutically.
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